| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162285 Anti-infective agents |
| 08/19/2004 | CA2514940A1 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | CA2495271A1 Synthesis of gatifloxacin |
| 08/18/2004 | EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 08/18/2004 | EP1447402A1 Quinoline compound |
| 08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 08/18/2004 | EP1446120A1 Stereospecific enrichment of heterocyclic enantiomers |
| 08/18/2004 | EP1446116A1 Inhibitors of dipeptidyl peptidase iv |
| 08/18/2004 | EP1294366B1 Pharmaceutical compounds for treating copd |
| 08/18/2004 | EP0876345B1 Heterocyclic compounds as h+-atpases |
| 08/18/2004 | CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor |
| 08/18/2004 | CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 08/18/2004 | CN1522244A Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/18/2004 | CN1162425C 4-hydroxyl-piperidine derivative |
| 08/18/2004 | CN1162424C Quinoline-4-yl derivative II |
| 08/17/2004 | US6777553 Using substituted-4-haloquinolines and the sodium, potassium or ammonium salts of dithiocarbamic acid which avoids the handling of hazardous and corrosive chlorosulphonic acid |
| 08/17/2004 | US6777552 From an ester derivative or protected ester derivative of the statin by using calcium hydroxide |
| 08/17/2004 | US6777532 Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 08/17/2004 | US6777427 Tetrahydroquinoline compounds |
| 08/12/2004 | WO2004067675A2 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 08/12/2004 | WO2004067513A1 Antagonists for alpha-2 adrenoceptors |
| 08/12/2004 | WO2004067502A1 Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23 |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004056779A3 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 08/12/2004 | WO2004043362A3 Acyl guanidine compounds and use thereof |
| 08/12/2004 | WO2003053980A8 Rare earth metal compounds and mixtures of these |
| 08/12/2004 | WO2002076395A3 Agents and methods for treatment of cancer |
| 08/12/2004 | US20040158076 Tyrosine derivatives |
| 08/12/2004 | US20040157880 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 08/12/2004 | US20040157865 exhibit activity in animal models of hyperalgesia and colitis, and are useful for the treatment and prevention of pain conditions in humans including arthritis, and for the treatment of irritable-bowel syndrome |
| 08/12/2004 | US20040157850 Novel heterocyclic derivatives |
| 08/12/2004 | US20040157836 Sulfonamides having antiangiogenic and anticancer activity |
| 08/12/2004 | US20040157818 antagonism to chemokine receptor CXCR4 for treatment of rheumatism or cancer metastasis |
| 08/12/2004 | US20040157741 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 08/12/2004 | CA2511941A1 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/11/2004 | EP1445250A1 Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same |
| 08/11/2004 | EP1444197A1 Novel phenyl-propargylether derivatives |
| 08/11/2004 | EP1444196A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives |
| 08/11/2004 | EP1443928A2 Treatment of neurodegenerative diseases and cancer of the brain |
| 08/11/2004 | CN1520702A Electroluminescent irisium compounds with fluorinated phenylpyridines, phenylpyridines and phenylquinolines and device made with such compounds |
| 08/11/2004 | CN1519232A Method for composing ethoxy quinoline |
| 08/11/2004 | CN1161337C Chinolinelone derivative its prepn. method and antiabnormal reaction agent |
| 08/11/2004 | CN1161336C Quinolinecarboxamides as antiviral agents |
| 08/11/2004 | CN1161331C Hydrazine derivatives |
| 08/10/2004 | US6774263 Pharmaceutically active compound and methods of use |
| 08/10/2004 | US6774086 Herbicides |
| 08/05/2004 | WO2004065539A2 Androgen receptor antagonists |
| 08/05/2004 | WO2004065379A1 Androgen receptor antagonists |
| 08/05/2004 | WO2004065353A1 Compounds for the inhibition of rotamases |
| 08/05/2004 | WO2004065351A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 08/05/2004 | WO2004064972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 08/05/2004 | WO2004056780A3 Tetrahydroquinoline derivatives |
| 08/05/2004 | US20040152741 Arylglycine derivatives and their use as glycine transport inhibitors |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152729 Using a 4-((ho-phenyl)-nh-)quinoline compound |
| 08/05/2004 | US20040152728 4-Quinolinol derivatives and fungicides containing the same as an active ingredient used for agriculture and horticulture |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152719 Quinolones with anti-HIV activity |
| 08/05/2004 | US20040152704 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/05/2004 | US20040151945 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 08/05/2004 | CA2513349A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 08/05/2004 | CA2511491A1 Androgen receptor antagonists |
| 08/05/2004 | CA2511089A1 Androgen receptor antagonists |
| 08/04/2004 | EP1442094A2 Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds |
| 08/04/2004 | EP1442032A1 Heterocyclic retinoid compounds |
| 08/04/2004 | EP1442021A1 Substituted 1h-quinolin-2-one compounds |
| 08/04/2004 | EP1442020A1 Heterocyclic derivatives of glycinamide and their medical use |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP1077957B1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 08/04/2004 | CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 08/04/2004 | CN1518449A Pediatric formulation of gatifloxacin |
| 08/04/2004 | CN1517427A Compound with red light and organic electroluminescence device using the compound |
| 08/03/2004 | US6770668 Pharmaceutically active compounds and methods of use |
| 08/03/2004 | US6770650 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 08/03/2004 | US6770648 Antidiabetic agents |
| 08/03/2004 | CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 07/29/2004 | WO2004063365A1 NOVEL USE OF COMPOUND HAVING TGFβ-INHIBITORY ACTIVITY |
| 07/29/2004 | WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | WO2004062571A2 Substantially pure cilostazol and processes for making same |
| 07/29/2004 | WO2004033423A3 Anticancer compounds |
| 07/29/2004 | US20040147758 Compounds for treatment of AIDS with enzyme inhibitors |
| 07/29/2004 | US20040147750 Process for preparation of a quinolinecarbaldehyde |
| 07/29/2004 | US20040147749 Modulate large conductance calcium-activated potassium ion channels; storage stability |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147503 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; antitumor agents; glomerulonephritis |
| 07/29/2004 | US20040146554 Providing an active pharmaceutical compound; providing a basic salt as one of a powder, a suspension and a solution having a pH greater than 7; combining; delivering the non-enteric coated liquid formulation |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/28/2004 | EP1440052A1 Benzamide derivatives as antagonists of orexin receptors |
| 07/28/2004 | EP1176958B1 Novel catechols as antimicrobial agents |
| 07/28/2004 | CN1516713A Polymers and oligomers, their synthesis, and electronic devices incorporating same |